Generic Drugs Market Report, Industry Trends, Growth, Share, Size, Region and Forecast Till 2023

1. GlobalGeneric Drugs Market Research Report, Share, Size, Growth and Outlook By 2023 Copyright © IMARC Service Pvt Ltd. All Rights Reserved

2. About IMARC Group Report Description IMARC is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Generic Drugs Market Report By Drug Delivery (Oral, Injectables, Dermal/Topical and Inhalers), Therapy Area (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology and Others), Distribution Channel, Region Over the recent years, the global generic drugs market has been witnessing a healthy growth. Some of the factors which are bolstering the market include low capital investment, approval from FDA or other assigned authority and encouragement from the government. Market Overview: Generic drugs are considered as bioequivalent of branded drugs as they are similar in terms of quality, strength, dosage and intended use. They require low capital investment as they only incur the manufacturing cost without the expenditure on drug discovery, drug development, advertising, distribution of free samples, etc. This results in an overall reduction of the generic drug manufacturing prices. On account of this, generic drugs form an integral part of the public healthcare schemes, in both the developed as well as developing countries. A new research report by IMARC Group, titled “Generic Drugs Market: Global Industry Trends, Manufacturing Process, Share, Size, Growth, Opportunity and Forecast 2018-2023”, estimates that the global generic drugs market was worth around US$ 315 Billion in 2017. The report further expects the market to reach US$ 474 Billion by 2023, at a projected CAGR of 6.8% over the forecast period.

4. Report Description and Highlights Report Description • Global Generic Drugs Market Drivers/Constraints: • As compared to the branded drugs, generic drugs are regarded cost-effective as they are 40-60% cheaper. This acts as one of the vital factors which is augmenting the demand for generic drugs across the globe. • Generic drugs are completely safe and reliable as they are inspected, approved and regulated by the FDA or other assigned authorities. This coupled with growing awareness about generic drugs has facilitated the growth of the market. • Governments of several nations are encouraging the use of generic drugs so as to reduce the expenditure incurred on the healthcare sector. In line with this, various campaigns are being undertaken with the objective of substituting the branded drugs with generic drugs. • A rise in the number of chronic diseases like diabetes, cardiovascular diseases, Parkinson’s disease, Alzheimer’s disease, etc. is further creating opportunities for the generic drug manufacturers, particularly in countries with an increasing geriatric population. • There are some factors which are hampering the growth of the generic drugs market. For instance, these drugs are perceived inferior by few consumers as they contain different inactive ingredients. • Request for a sample report: • https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample

5. Market Forecast Sample Figure: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2018 - 2023

6. Market Segmentation Report Description • Generic Drugs Market Segmentation: • Market Segmentation by Drug Delivery • Oral • Injectables • Dermal/Topical • Inhalers • Based on drug delivery, oral generic drugs represent the most popular segment, holding the largest market share. Oral generic drugs are generally preferred owing to the convenience attached with their administration which requires minimal or no medical assistance. Other major segments include injectables, dermal/topical and inhalers. • Market Segmentation by Therapy Area • CNS • Cardiovascular • For more information, click here: https://www.imarcgroup.com/generic-drug-manufacturing-plant

7. Market Segmentation Report Description • Dermatology • Genitourinary/Hormonal • Respiratory • Rheumatology • Diabetes • Oncology • Others • On the basis of therapy area, the market has been divided into CNS, cardiovascular, dermatology, genitourinary/hormonal, respiratory, rheumatology, diabetes and oncology. Amongst these, cardiovascular diseases hold the largest share, accounting for the majority of total market. This can be accredited to the increasing cases of cardiovascular diseases as a result of sedentary lifestyles and unhealthy eating habits. • Market Segmentation by Region • North America • Europe • Asia Pacific • Latin America • Middle East and Africa

8. Regional Segmentation North America Europe Asia- Pacific Middle East and Africa Latin America

9. Market Segmentation Report Description • On a geographical front, the United States enjoys the leading position in the global generic drugs market on account of favorable regulations by the Government. It is followed by China, Brazil, Germany, France, India, United Kingdom, Japan, Canada and Italy. • Market Segmentation by Distribution Channel • Retail Pharmacies • Hospital Pharmacies • On the basis of distribution channel, retail pharmacy stores dominate the market, representing the largest segment. Customer-service plays a significant role for a retail pharmacist as patients tend to interact directly with them while purchasing medication. Retail pharmacy stores are followed by hospitals. • Competitive Landscape: • On analyzing the competitive landscape, it has been found that the market is highly fragmented with the presence of numerous manufacturers. Some of the largest players operative in the market are: • Teva Pharmaceuticals

10. Market Segmentation Report Description • Mylan NV • Sandoz (Novartis) • Hospira (Pfizer Inc.) • Sun Pharmaceutical Industries Ltd. • Fresenius Kabi Ag • Lupin • Endo Pharma • Aurbindo Pharma • Aspen Pharmacare • In case you have a very specific customized or specific niche needs, we can work around the scope of work and assist you with the tailor made solution. The topics covered could be technology, markets, competition, pricing trends, P&L analysis, cost analysis, price bench marking or it could also be supplementing you with the weekly or fortnight reports.

11. Team Profile Our Team Comes From Some of the Top Universities Globally. Team Profile 60% Engineering and Science 5% Others 35% Business Studies Average Experience of 7+ Years Over 2000 Independent Consultants from different sectors.

12. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

13. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

14. Report Description and Highlights Report Description © 2018 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

15. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: • TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com